Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 22999236)

1.

Glucose control and cardiovascular outcomes in individuals with diabetes mellitus: lessons learned from the megatrials.

Avitabile NA, Banka A, Fonseca VA.

Heart Fail Clin. 2012 Oct;8(4):513-22. doi: 10.1016/j.hfc.2012.06.009. Epub 2012 Aug 11. Review.

PMID:
22999236
2.

Intensive glycemic control and cardiovascular disease: an update.

Brown A, Reynolds LR, Bruemmer D.

Nat Rev Cardiol. 2010 Jul;7(7):369-75. doi: 10.1038/nrcardio.2010.35. Epub 2010 Apr 20. Review.

PMID:
20404853
3.

Glucose control and vascular complications in veterans with type 2 diabetes.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators.

N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1024-5. N Engl J Med. 2009 Sep 3;361(10):1028.

4.

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.

PMID:
9706116
5.

Glycemic management in diabetes and the associated cardiovascular risk: are we helping or hurting our patients?

Koshizaka M, Green JB, Alexander JH.

Circ J. 2012;76(7):1572-80. Epub 2012 Jun 16. Review.

7.

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.

PMID:
14583175
8.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

9.

Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.

Dailey G.

Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025. Review.

PMID:
21704233
11.

[Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].

Ilyés I, Jancsó Z, Kovács E, Márton H, Simay A.

Orv Hetil. 2005 Dec 18;146(51):2581-8. Hungarian.

PMID:
16468612
12.

Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes.

Brown SH, Abdelhafiz AH.

Postgrad Med. 2009 Sep;121(5):31-41. doi: 10.3810/pgm.2009.09.2050. Review.

PMID:
19820272
13.

The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes.

Yu PC, Bosnyak Z, Ceriello A.

Diabetes Res Clin Pract. 2010 Jul;89(1):1-9. doi: 10.1016/j.diabres.2009.12.009. Epub 2010 May 21. Review.

PMID:
20494468
14.

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

Diabetes Care. 1995 Aug;18(8):1113-23.

PMID:
7587846
15.

Glucose lowering and cardiovascular disease: what do we know and what should we do?

Cheng AY, Leiter LA.

Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S25-31. doi: 10.1097/01.hjr.0000368194.32356.5f. Review.

PMID:
20489417
17.

[Treatment of diabetes in metabolic syndrome].

Pelikánova T.

Vnitr Lek. 2009 Jul-Aug;55(7-8):637-45. Review. Czech.

PMID:
19731868
18.

Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.

Tandon N, Ali MK, Narayan KM.

Am J Cardiovasc Drugs. 2012 Feb 1;12(1):7-22. doi: 10.2165/11594650-000000000-00000. Review.

PMID:
22217193
19.

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.

Shogbon AO, Levy SB.

Am J Health Syst Pharm. 2010 May 15;67(10):798-805. doi: 10.2146/ajhp090211. Review.

PMID:
20479101
20.

Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.

Tkác I.

Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S57-62. doi: 10.1016/S0168-8227(09)70011-7.

PMID:
20115934
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk